SIGA Technologies Says Japan's Pharmaceutical Regulator Approves Its Antiviral Treatment for Smallpox, MPox, Cowpox
SIGA Technologies Says Japan's Pharmaceutical Regulator Approves Its Antiviral Treatment for Smallpox, MPox, Cowpox
SIGA Technologies表示,日本的藥品監管機構批准了其針對天花、猴痘和牛痘的抗病毒治療方案。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。